Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia | Annals of Hematology
Event-free survival curves. The Kaplan-Meier curves demonstrate no... | Download Scientific Diagram
Disease-free Survival and Invasive-Disease-free Survival in the... | Download Scientific Diagram
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
Kaplan–Meier Estimates of Event-free and Overall Survival among... | Download Scientific Diagram
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Predictors of Long-Term Outcome after Percutaneous Balloon Mitral Valvuloplasty | NEJM
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer | NEJM
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma | NEJM
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial - The Lancet Oncology
Survival Analysis in Python (KM Estimate, Cox-PH and AFT Model) | by Rahul Raoniar | The Researchers' Guide | Medium
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group | Haematologica
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments - ScienceDirect
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial - The Lancet Oncology
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Event-free survival and overall survival (A) Event-free survival for... | Download Scientific Diagram
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia | Bone Marrow Transplantation
Progression-free survival (PFS), event-free survival (EFS), and overall... | Download Scientific Diagram
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia | Nature Communications
